Moderna plans to submit an application to the US health regulator for emergency use authorization (EUA) of its Covid-19 vaccine among kids between the ages of six months to five years by end of the month. The Omicron variant was predominant during Moderna's pediatric trial, and the drugmaker said two doses were around 38% effective in preventing infections in 2 to 5-year-olds and 44% effective for children aged 6 months to under 2 years.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/iLs36GK
via gqrds
Moderna to file for EUA of Covid-19 shot for very young kids by April end
Moderna to file for EUA of Covid-19 shot for very young kids by April end Moderna plans to submit an application to the US health regulator for emergency use authorization (EUA) of its Covid-19 vaccine among kids between the ages of six months to five years by end of the month. The Omicron variant was predominant during Moderna's pediatric trial, and the drugmaker said two doses were around 38% effective in preventing infections in 2 to 5-year-olds and 44% effective for children aged 6 months to under 2 years. https://ift.tt/KYGLC5f
India registers 2,380 new COVID-19 cases, 56 deaths, active caseload at 13,433
India registers 2,380 new COVID-19 cases, 56 deaths, active caseload at 13,433 1,231 patients have recovered in the last 24 hours. Consequently, India’s recovery rate stands at 98.76 per cent. https://ift.tt/KYGLC5f
Mask-optional public transit alarms immunocompromised people and their families
Mask-optional public transit alarms immunocompromised people and their families
https://ift.tt/8V5D7fp April 21, 2022 at 01:40AM https://ift.tt/Usv8fO9
 |
submitted by /u/shallah [link] [comments] |
Subscribe to:
Posts (Atom)
Popular Posts
|
